HEALTHEQUITY, INC. (HQY) Form 10-Q — Aug 27, 2026

$HQYForm 10-QFiled Aug 27, 2026, 8:04 AM ET0001428336-26-000041Original filing

HealthEquity filed its Form 10-Q for the quarter ended July 31, 2026, reporting revenue of $350.7 million, up 8% year over year, with net income of $65.6 million, up 10%, and diluted EPS of $0.78 versus $0.68 a year earlier. For the first six months of fiscal 2027, revenue rose 7% to $705.4 million and net income climbed 19% to $135.1 million, while Adjusted EBITDA grew 14% to $331.5 million. The company administered 10.7 million HSAs, up 8%, with HSA Assets of $37.9 billion, up 14%, though CDB accounts slipped 2% to 7.0 million.

Key figures

Eps: $0.78 diluted Q2 (vs $0.68); $1.60 diluted six months (vs $1.29); non-GAAP $1.24 Q2
Revenue: $350.7 million Q2 (+8% YoY); $705.4 million six months (+7% YoY)
Net Income: $65.6 million Q2 (+10%); $135.1 million six months (+19%)
Total Debt: $935.0 million principal ($600.0 million 4.50% Senior Notes due 2029; $335.0 million revolver)
Revenue Yoy: 8% (Q2); 7% (six months)
Total Assets: $3.27 billion
Cash Position: $256.0 million
Interest Rate: 4.50% fixed on Senior Notes; 5.08% on revolver as of July 31, 2026
Maturity Date: October 1, 2029 (Senior Notes); August 23, 2029 (Revolving Credit Facility)
Shares Outstanding: 82715296
Hsa Assets: $37.9 billion (+14% YoY)
New Hsas Ytd: 374 thousand (+20% YoY)
Aoci Balance: -$69.1 million unrealized loss on cash flow hedges
Cdb Accounts: 7.0 million CDBs (-2% YoY)
Hsa Accounts: 10.7 million HSAs (+8% YoY)
Hsa Cash Yield: 3.83% average annualized yield vs 3.51% prior year
Total Accounts: 17.8 million Total Accounts (+4% YoY)
Adjusted EBITDA: $167.0 million Q2 (+11%); $331.5 million six months (+14%)
Hsa Investments: $20.6 billion (+28% YoY)
Client Held Funds: $931 million
Buybacks Six Months: $231.1 million
Derivative Notional: $3.035 billion Treasury bond forwards
Operating Cash Flow Six Months: $233.7 million
Remaining Buyback Authorization: $948.4 million

Price after filing

1 day: 0.0%7 days: -5.4%30 days: -15.5%

Close on the filing date to close N calendar days later (from $104.42). Historical, not a forecast.

AI analysis

Red flags5 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.